Aug 29, 2011 08:20 EDT nxt2b (Nexttobe AB) an investment company owned by Bengt Ågerup, has today signed an agreement with a group of shareholders in Olink AB to purchase 49 % of the outstanding shares in the company. The intention is to accelerate the growth and value creation of the company by injecting knowledge, experience and financial strength to complement Olink’s unique product and technology position.
Image
Duolink® II Reagent Kit
Mar 02, 2011 04:41 EST
Size:240 KB
Format:jpg
Image dimensions:975 x 649 pixels
Download
Categorization
- Topics:
- Research,
- Health, Health Care, Pharmaceuticals,
- Medicine,
- Medical research,
- Science, technology
Add commentThe comment was saved
Prior to publication, it must be approved by Olink Bioscience.